Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | AMGN | BMY | GILD | VRTX |
| Company | Clovis Oncology Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0808 | 270.63 | 49.00 | 66.58 | 404.50 |
| High | 0.0977 | 274.86 | 49.05 | 67.18 | 406.83 |
| Low | 0.0766 | 269.64 | 48.55 | 66.36 | 399.29 |
| Last | 0.0812 | 273.01 | 48.86 | 67.08 | 400.76 |
| Change | -0.0048 | -0.53 | -0.13 | +0.05 | -4.15 |
| % Change | -5.58% | -0.19% | -0.27% | +0.07% | -1.02% |
| Volume | 24,516,400 | 2,467,100 | 16,057,100 | 8,467,000 | 806,400 |
| 20-Day Average Volume | 9,433,500 | 2,172,705 | 11,259,110 | 6,490,535 | 970,000 |
| Previous Close | 0.0860 | 273.54 | 48.99 | 67.03 | 404.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 271.55 | 50.37 | 69.07 | 403.29 |
| 20-Day Raw Stochastic | 1.73% | 44.22% | 18.15% | 14.81% | 32.03% |
| 20-Day Relative Strength | 23.83% | 48.18% | 41.15% | 33.12% | 44.82% |
| Weighted Alpha | -91.19 | +11.15 | -26.02 | -20.78 | +16.09 |
| Today's Opinion | 100% Sell | 40% Sell | 88% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 88% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Sell | 24% Buy | 8% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +3.39% since 04/17/24 | +2.13% since 04/17/24 | +0.22% since 04/17/24 | +1.95% since 04/17/24 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 0.1439 on 12/14/22 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -1.14% since 03/22/24 | -5.91% since 03/22/24 | -7.62% since 03/22/24 | -3.58% since 03/22/24 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 0.3772 on 12/01/22 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -10.64% since 01/24/24 | -2.75% since 01/24/24 | -15.65% since 01/24/24 | -6.27% since 01/24/24 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 1.3100 on 10/04/22 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -1.13% since 10/24/23 | -12.94% since 10/24/23 | -14.17% since 10/24/23 | +8.50% since 10/24/23 |
| Low | 0.0760 on 12/16/22 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 3.2500 on 07/08/22 | 329.72 on 02/05/24 | 56.77 on 10/25/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 146,720,288 | 99,290,928 | 83,457,512 | 104,652,640 |
| Shares Outstanding, K | 144,955 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 148,760,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -264,520,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 30,660,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -56,010,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 0.24 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 11/09/22 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.58 | 6.55 | 9.96 | 29.76 |